Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson’s disease

Parkinson’s disease (PD), classically defined as a progressive motor disorder accompanied with dopaminergic neuron loss and presence of Lewy bodies, is the second most common neurodegenerative disease. PD also has various non-classical symptoms, including cognitive impairments. In addition, inflamma...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Brain
Päätekijät: Stanojlovic, Milos, Pallais, Jean Pierre, Lee, Michael K., Kotz, Catherine M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822428/
https://ncbi.nlm.nih.gov/pubmed/31666100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13041-019-0514-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia